Shanghai OPM Biosciences Bolsters Growth with Strategic Acquisition of Penglai Biopharmaceutical Technology
Shanghai OPM Biosciences Co Ltd has announced plans to acquire Penglai Biopharmaceutical Technology, a move expected to enhance its capabilities and market position in the biotechnology sector.
2 minutes to read